COST EFFECTIVENESS IN ONCOLOGY
Copyright policy )COST EFFECTIVENESS IN ONCOLOGY
Adult, Cost Control, National Health Programs, Economics, Cost-Benefit Analysis, Biomedical Technology, Antineoplastic Agents, Medical Oncology, Resource Allocation, Neoplasms, Humans, Child, Health Care Rationing, Patient Selection, Research, Palliative Care, Hospices, Combined Modality Therapy, Home Care Services, Hospitals, United Kingdom, Pharmaceutical Preparations, Evaluation Studies as Topic, General Surgery, Quality of Life, Patient Care, Radiology, Delivery of Health Care
Adult, Cost Control, National Health Programs, Economics, Cost-Benefit Analysis, Biomedical Technology, Antineoplastic Agents, Medical Oncology, Resource Allocation, Neoplasms, Humans, Child, Health Care Rationing, Patient Selection, Research, Palliative Care, Hospices, Combined Modality Therapy, Home Care Services, Hospitals, United Kingdom, Pharmaceutical Preparations, Evaluation Studies as Topic, General Surgery, Quality of Life, Patient Care, Radiology, Delivery of Health Care
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).58 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!